PDS Biotechnology
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -15 | -14 | -14 | |
EBITDA | -9,506 | -7,993 | -9,414 | -9,709 |
EBIT | -9,511 | -8,009 | -9,428 | -9,723 |
Net Income | -10,726 | -8,327 | -10,603 | -10,898 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -26,776,958 | -8,886 | -9,938 | -8,457 |
Cash | 49,751 | 57,733 | 66,634 | 56,560 |
Basic Shares | 36,806 | 36,693 | 34,815 | 31,669 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -57 | -49 | -246 | -176 |
EBITDA | -40,084 | -41,623 | -21,188 | -14,671 |
EBIT | -40,142 | -41,672 | -21,434 | -14,847 |
Net Income | -42,942 | -40,854 | -16,918 | -14,847 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 8,577 | 16,677 | ||
Free Cash Flow | -33,636 | -25,709 | -12,486 | -13,149 |
Cash | 56,560 | 73,820 | 65,242 | 28,839 |
Basic Shares | 30,952 | 28,599 | 25,597 | 16,745 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.29 |
2024-06-30 | -$0.23 |
2024-03-31 | -$0.30 |
2023-12-31 | -$0.35 |
